Whether you use Ozempic for type 2 diabetes, kidney disease (if you also have type 2 diabetes), or off-label for weight loss, you may wonder how drinking alcohol may affect the drug. (Off-label ...

A new study published in JAMA Ophthalmology reveals that weight loss drugs like Ozempic and similar medications could cause three potentially blinding eye conditions. The research identified ...

Ozempic and other semaglutide drugs help people reduce their drinking, a new study has found. The drugs, best known for their use in weight loss and diabetes treatment, also appeared to reduce how ...

Steve Christo - Corbis/Corbis via Getty; Getty It has been theorized that Ozempic could potentially help with substance abuse disorders due to the way it works in the brain. Now the first clinical ...

Patients taking Ozempic and similar weight loss drugs are reporting cases of sudden vision loss, including temporary and even permanent blindness. While these claims have circulated on Reddit for ...

As drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more cases linking them to severe eye conditions. As the researchers note, all but one of the study ...

DOCTOR, GOOD TO SEE YOU. YOU’VE LOOKED AT THIS NEW STUDY ABOUT OZEMPIC. AND FIRST OF ALL, IS IT OZEMPIC SPECIFICALLY? AND WHAT DOES IT SHOW? SO IT’S LOOKING SPECIFICALLY AT OZEMPIC ...

(Reuters) - Novo Nordisk’s blockbuster GLP-1 diabetes drug Ozempic led to improvements in some measures of alcohol use disorder in a small trial, researchers reported on Wednesday. The 48 ...

Semaglutide was a top-selling drug in 2023, and its popularity only continues to grow, as it’s been increasingly prescribed off-label for ... price for Ozempic is $997.58 per pen without insurance.

Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their intake. The research found that, compared to placebo, weekly injections of ...

Semaglutide, sold by Novo Nordisk as Ozempic for type 2 diabetes and Wegovy for obesity, is part of a class of drugs known as GLP-1 receptor agonists, mimicking the hormone GLP-1 to reduce ...